Single partner

Polypharma offers a unique blend of services and skills that make it possible for it to act as a single partner accompanying local companies all the way from selection of target product through to actual receipt of raw materials for production.

“Over the years we have developed more than 200 approved drug dossiers for our partners, meeting real local needs, along with tech transfer and up-scaling services to succeed with their own production,” noted Polypharma founder and general manager, Mohamed Ben M’Barek.

Facilitating local production

At the time Polypharma was born, a very high percentage of African and Middle Eastern medicines were imported from Europe and North America as well as Asia, with limited local production largely carried out by public institutions, typically producing generics under license. Almost total absence of laboratories also made it very challenging to check imported medicines for quality or efficacy.

Read the whole article here: